VEGFA and age-related macular degeneration: Along with their oncologic effects, VEGF antagonists have also been shown to greatly decrease the angiogenesis and vascular leakage associated with pathogenic causes of blindness and vision loss, such as Diabetic Retinopathy (DR) and Age-Related Macular Degeneration (AMD) [6].